Immunome, Inc.
IMNM
$27.20
$0.782.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.75% | -9.50% | 27.50% | 27.05% | 19.12% |
| Total Depreciation and Amortization | 31.05% | 16.26% | 40.58% | 57.26% | 92.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.18% | -34.70% | -79.57% | -77.70% | -74.71% |
| Change in Net Operating Assets | 108.91% | -77.59% | -202.37% | -891.46% | -230.92% |
| Cash from Operations | -16.85% | -28.70% | -72.32% | -114.66% | -194.66% |
| Capital Expenditure | -42.27% | -4.01% | -35.02% | -6.50% | -47.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -934.91% | 254.74% | 190.50% | 163.72% | 88.27% |
| Cash from Investing | -678.89% | 202.23% | 171.48% | 159.73% | 83.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 162.05% | 160.34% | 165.80% | 1.73% | -17.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -155.88% | -153.81% | -159.10% | -129.96% | -111.20% |
| Cash from Financing | 162.43% | 160.75% | 166.23% | -17.50% | -45.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 445.87% | 2,785.30% | 1,042.19% | 80.48% | -116.82% |